Silver Book Fact

Economics of DR Treatment

Fact image

Laser treatment plus a VEGF inhibitor achieved an incremental cost-effectiveness ratio of $12,410 per quality adjusted life year in patients with DME.

Pershing S, Enns E, Matesic B, Owens D, Goldhaber-Feibert J. Cost-Effectiveness of Treatment of Diabetic Macular Edema. Ann Intern Med. 2014; 160(1): 160-3. http://annals.org/article.aspx?articleid=1811027

Reference

Title
Cost-Effectiveness of Treatment of Diabetic Macular Edema
Publication
Ann Intern Med
Publication Date
2014
Authors
Pershing S, Enns E, Matesic B, Owens D, Goldhaber-Feibert J
Volume & Issue
Volume 160, Issue 1
Pages
160-3
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Laser Treatment for DR
    Laser treatment of PDR can reduce the 5-year risk of blindness by 90%, and the risk of visual loss from DME by 50%.  
  • One economic model predicts that if type 1 and type 2 diabetics had begun Captopril (a drug that controls blood pressure and delays the onset of kidney failure) treatment in…  
  • LDL-C Screening: Trends, 1998-2006  
  • 150 drugs are in development for diabetes. Diabetes affects 12.2 million Americans age 60 and older.  
  • In general, for every 10 mmHg reduction in systolic blood pressure, the risk for any complication related to diabetes is reduced by 12%.